ClinicalTrials.Veeva

Menu

mHealth for Psychosis Help-seeking

University of Washington logo

University of Washington

Status

Completed

Conditions

Psychosis

Treatments

Behavioral: NORTH "Full"
Behavioral: NORTH "Lite"

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05905601
K23MH122504-01 (U.S. NIH Grant/Contract)
STUDY00009039

Details and patient eligibility

About

The proposed study research project aims to develop and test a mobile health intervention designed to improve the wellness of young people at risk for psychosis and facilitate users' engagement with treatment and thus reduce duration of untreated psychosis. This clinical trial will involve a remote pilot randomized controlled trial that will examine (1) the feasibility of the proposed research approach, (2) the acceptability and usability of the NORTH intervention as well as (3) the specific additive value of help-seeking support in the context of self-guided mHealth for early psychosis. The full intervention, which includes psychoeducational lessons, Cognitive-Behavior Therapy-based practices, a symptom tracking feature, and help-seeking resources will be compared to a "Lite" version that will include the lessons, practices, and tracking but exclude the help-seeking resources.

Enrollment

60 patients

Sex

All

Ages

18 to 30 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Elevated risk for psychosis that warrants further evaluation (a distress score >= 20 on the Prodromal Questionnaire, Brief [PQ-B], per Savill et al., 2018; and a positive frequency average score >= 1.47 on the Community Assessment of Psychic Experiences [CAPE-P15], per Jaya et al., 2021 and Bukenaite et al., 2017) and confirmation of symptoms consistent with online data collection checks (per Moritz et al., 2013)
  • Age 18-30 years old
  • Lives in the United States
  • Under five years since participant's first psychotic episode or awareness of symptom onset
  • Owns an iPhone
  • Unengaged in specialty mental health treatment, in which the participant has not done either of the following in the previous three months: (1) taken a prescribed antipsychotic medication, (2) attended regular (i.e. more than one session of) psychotherapy.

Exclusion criteria

  • Failed to demonstrate understanding of study details in comprehension screening process.
  • Engaged in specialty mental health treatment in the previous three months, defined as the following: (1) taken a prescribed antipsychotic medication, OR (2) attended regular (i.e. more than one session of) psychotherapy.
  • Unengaged in treatment, but only as a result of having completed or "graduated" from a specialty mental health program.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

NORTH "Full"
Experimental group
Description:
Participants in the experimental arm will be provided access to the "Full" NORTH smartphone application designed to support young adults at risk for psychosis. They will also have access to the research team by phone for technical troubleshooting and support as necessary.
Treatment:
Behavioral: NORTH "Full"
NORTH "Lite"
Experimental group
Description:
Participants in the control arm will be provided access to the NORTH "Lite" smartphone application designed to support young adults at risk for psychosis. They will also have access to the research team by phone for technical troubleshooting and support as necessary.
Treatment:
Behavioral: NORTH "Lite"

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Erica Whiting, BS; Benjamin E Buck, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems